NCT00731419

Brief Summary

Background: When considering any malignancy with limited life expectancy, palliation and quality of life are paramount. Owing to the limited centres offering ERCP and endoscopic palliation in the South African state sector, patients often travel vast distances and spend large amounts of time away from family and social support structures, severely impairing their quality of life. Stent occlusion with resultant readmission to an ERCP accredited centre obviously compounds this problem. The hypothesis we propose to test is whether metal stents as a primary procedure result in better patency rates, are more cost effective and improve quality of life than plastic stents. We propose to do this by means of a randomised trial determining the best method of palliation for inoperable distal common bile duct malignancies in the South African context. Primary end-point Assessing the cost of metal versus plastic stenting in inoperable malignant distal common bile duct strictures in patients with expected survival of 3 months or more as palliation of symptomatic obstructive jaundice. Cost to be assessed in terms of hardware, hospital stay and readmissions for stent occlusion(patency) and complications Secondary end-point Assessing quality of life using a validated scoring system(EORTC QLQ 30) in patients receiving a metal or plastic biliary stent as definitive means of palliation of malignant obstructive jaundice Hypothesis to be tested Metal stents are superior to plastic stents in terms of patency, resulting in more cost effective palliation of inoperable malignant jaundice and better quality of life due to fewer stent occlusions/episodes of cholangitis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Jun 2007

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2007

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

August 5, 2008

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 11, 2008

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2009

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2009

Completed
Last Updated

August 11, 2008

Status Verified

May 1, 2007

Enrollment Period

1.9 years

First QC Date

August 5, 2008

Last Update Submit

August 5, 2008

Conditions

Keywords

biliaryobstructionmalignantstentpalliation

Outcome Measures

Primary Outcomes (1)

  • Overall cost comparison of metal versus plastic stent in patients with limited life expectancy

    6 months

Secondary Outcomes (1)

  • Quality of life assessment

    6 months

Study Arms (2)

SEMS

ACTIVE COMPARATOR

Self expanding metal stent compared to plastic stent. Both recognised forms of treatment for condition

Device: SEMS

Plastic stent

ACTIVE COMPARATOR
Device: SEMS

Interventions

SEMSDEVICE

Comparing plastic and metal stents

Also known as: Boston Scientific, biliary self-expanding metal stent, olympus plastic stent
Plastic stentSEMS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Symptomatic jaundice secondary to malignant distal CBD stricture
  • Contra-indication to resection (advanced disease/advanced age/poor surgical risk)

You may not qualify if:

  • Hilar/proximal CBD obstruction
  • ECOG performance status 3 or 4
  • Duodenal obstruction
  • Previous stent placement
  • Inability to comply with follow-up
  • Ascites and liver metastases
  • Not possible to stent endoscopically

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groote Schuur Hospital

Cape Town, Western Cape, 7925, South Africa

RECRUITING

MeSH Terms

Conditions

Bites and Stings

Condition Hierarchy (Ancestors)

PoisoningChemically-Induced DisordersWounds and Injuries

Study Officials

  • John M Shaw, FCS, MMed

    University of Cape Town

    PRINCIPAL INVESTIGATOR

Central Study Contacts

John M Shaw, FCS, MMed

CONTACT

Jake E Krige, FCS, FACS

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 5, 2008

First Posted

August 11, 2008

Study Start

June 1, 2007

Primary Completion

May 1, 2009

Study Completion

August 1, 2009

Last Updated

August 11, 2008

Record last verified: 2007-05

Locations